Siddha drug veppampoo Mathirai for Blood pressure
- Conditions
- Diseases of the circulatory system,
- Registration Number
- CTRI/2022/02/040005
- Lead Sponsor
- Self
- Brief Summary
This is an open clinical interventional evaluation of Siddha drug Veppampoo Mathirai for Systemic Hypertension. Both gender of age 18-60 will be enrolled based on inclusion and exclusion criteria. Intervention will be given for 60 days and the outcome is assessed on the basis of systolic, diastolic and mean arterial pressure before and after treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 31
Newly diagnosed systemic Hypertension patients having blood pressure value systolic 140-179mmHg and diastolic 90-109mmHg, willing to give written consent to participate in the study.
Blood pressure value having systolic greater or equal to 180mmHg and diastolic greater or equal to 110mmHg, Secondary hypertension, Diabetes mellitus, cardiovascular disease/ hepatic disease, asthmatic and copd patients, pregnant women and lactating mothers, patients who are on steroids, oral contraceptive pills, oestrogen replacement therapy.participants will be excluded clinically or based on available medical reports.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome assessed by an expected reduction in blood pressure value of systolic 10-20mmHg and diastolic 5-15mmHg. 0 day and 61 day
- Secondary Outcome Measures
Name Time Method Liver and renal parameters compared before and after treatment. 0 day and 61 day
Trial Locations
- Locations (1)
Aringnar Anna Government hospital of Indian medicine
🇮🇳Chennai, TAMIL NADU, India
Aringnar Anna Government hospital of Indian medicine🇮🇳Chennai, TAMIL NADU, IndiaS M ChitraPrincipal investigator09444177230chittu758@gmail.com